Julie Cernanec, MD
Pediatric Hospital Medicine
Highlights
Age Groups Seen
- Child
- Adolescent
Languages
- English
Gender
FemaleAbout Julie Cernanec
Biography
Dr. Cernanec has cared for patients as a Staff physician in Pediatric Hospital Medicine since 2009. Prior to joining Cleveland Clinic, she earned her medical degree from Duke University School of Medicine and continued her training in Duke’s Pediatric Residency program. Dr. Cernanec is passionate about providing quality pediatric inpatient care with an emphasis on safety and efficiency. She has led hospital-wide efforts in readmissions reduction, documentation improvement, discharge planning, and continuous improvement and currently serves as the Vice Chair for Safety, Quality, and Patient Experience for the Children’s Institute. Dr. Cernanec is active in the national Solutions for Patient Safety collaborative, and is currently serving a three-year term as an Ohio Regional Co-Champion. Dr. Cernanec is board-certified in both General Pediatrics and Pediatric Hospital Medicine and has earned the Society of Hospital Medicine’s recognition as a Senior Fellow in Hospital Medicine. She enjoys teaching residents and medical students and is a Clinical Associate Professor of Pediatrics at Cleveland Clinic Lerner College of Medicine.
Education & Board Certifications
Education
- Residency: Duke University Medical Center , 2009
- Medical Education: Duke University School of Medicine, 2006
- Undergraduate: Duke University, 2000
Board Certifications
- Pediatric Hospital Medicine: American Board of Pediatrics, 2022
- Pediatrics: American Board of Pediatrics, 2009
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2026-01-02, Dr. Cernanec has reported no financial relationship with industry that is applicable to this listing.
In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.